People channel feed

How does Paul Hud­son's $13.5M comp pack­age stack up against oth­er CEOs? He's in the 'first quar­tile'

5 years ago

An Ar­ray co-founder re-emerges as CEO of a small aca­d­e­m­ic spin­out, look­ing to re­make an old class of can­cer drugs

5 years ago
Financing

With dust set­tled on ac­tivist at­tack, Lau­rence Coop­er leaves Zio­pharm to a new board

5 years ago

CMO Tal Zaks bids Mod­er­na a sur­prise adieu as biotech projects $18.4B in rev­enue, plots post-Covid ex­pan­sion

5 years ago
Manufacturing

Biden is look­ing be­yond Wood­cock or Sharf­stein for FDA com­mis­sion­er — re­port

5 years ago
FDA+

Japan's Soft­Bank plots bil­lions in biotech in­vest­ments in move that could keep the val­u­a­tion flood ris­ing — re­port

5 years ago
Financing

Stephen Hahn makes first post-FDA move, join­ing board of un­der-the-radar Philadel­phia com­pa­ny

5 years ago
Pharma

In­ter­cept shake­up con­tin­ues as CMO, for­mer NASH chief re­signs. Is the NASH biotech aban­don­ing its flag­ship dis­ease?

5 years ago

Jim Mullen won a $20M op­tion pack­age when he switched from chair­man to the CEO job at Ed­i­tas — and it's all tied to per­for­mance

5 years ago

Kite de­vel­op­ment head Ken Takeshi­ta jumps to Dai­ichi Sankyo amid on­col­o­gy push

5 years ago

Eli Lil­ly's David Ricks snared $24M pay pack­age in a year tur­bo-boost­ed by Covid-19 an­ti­body

5 years ago

Vas Narasimhan gets a bump in pay, but still falls well be­low some ri­vals

5 years ago

End­points Man­u­fac­tur­ing: 5 Ques­tions with Ho­mol­o­gy Med­i­cines

5 years ago
Manufacturing

Janet Wood­cock slams calls for FDA 'fire­wal­l' amid ad­u­canum­ab de­ba­cle, cit­ing need for col­lab­o­ra­tive drug de­vel­op­ment

5 years ago
FDA+

Eli Lil­ly adds new board mem­ber Kim­ber­ly John­son, the COO who helped lead Fan­nie Mae out of the US hous­ing cri­sis

5 years ago
Pharma

Gene edit­ing ex­pert Char­lie Al­bright tells us why he hopped from Ed­i­tas to a new role as CSO of an up­start biotech out to en­gi­neer gene ther­a­py 2.0

5 years ago

Ex­clu­sive: Af­ter four decades, one re­searcher's rad­i­cal HIV cure fi­nal­ly gets its shot

5 years ago
Startups
In Focus

'I’m not try­ing to re­build an ego': Neil Wood­ford ap­peals to pro­fes­sion­als for his come­back biotech fund

5 years ago
Financing

As­traZeneca's Pas­cal So­ri­ot picks up $21.5M pay pack­age in 2020, a big haul in year marked by Covid-19 shot de­vel­op­ment

5 years ago

Eli Lil­ly strips oust­ed CFO Josh Smi­ley of $24M in pay af­ter 'i­nap­pro­pri­ate mes­sages' scan­dal

5 years ago

SR One re­cruits an IPO vet and sea­soned ops chief for the ven­ture team. And they have some prac­ti­cal ad­vice for you

5 years ago

Months af­ter shock­ing house ar­rest, Leg­end co-founder Frank Zhang is out on bail — though the CAR-T play­er has moved on

5 years ago
China

Eli Lil­ly ousts CFO Josh Smi­ley af­ter 'i­nap­pro­pri­ate re­la­tion­ship' with em­ploy­ee, ap­points suc­ces­sor in Anat Ashke­nazi

5 years ago
Pharma

Mark Mal­lon wraps a short stint as CEO of Iron­wood, jump­ing out to pur­sue 'mul­ti­ple pas­sion­s' in the wake of set­backs

5 years ago
First page Previous page 60616263646566 Next page Last page
A service from the Financial Times